Drug intelligence / Profile preview

2'-[18F]fluoroflumazenil

Development stage
Preclinical
Lead developer
RadioMedic
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[18F]FFMZ (2'-[18F]fluoroflumazenil) is a positron emission tomography (PET) radiopharmaceutical developed by RadioMedic. It is a derivative of flumazenil, a benzodiazepine receptor antagonist, radiolabeled with fluorine-18. The tracer binds with high affinity to the benzodiazepine site of the GABA(A) receptor complex. It is designed for the non-invasive imaging of GABAergic system changes associated with various pathologies. Primary research areas include neurodegenerative conditions like Alzheimer's disease and epilepsy, where GABA receptor density may be altered. It is also being investigated for peripheral applications such as pulmonary ischemia and as a tool for monitoring chemotherapy efficacy.

Other names
2'-[18F]fluoroflumazenil[18F]flumazenil derivative
02

Targets

BZD site (GABA-A receptor benzodiazepine site)

Beyond the preview

Go deeper on 2'-[18F]fluoroflumazenil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2'-[18F]fluoroflumazenil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call